Literature DB >> 477721

Analysis of the effects of bromocriptine on blood pressure and sympathetic nerve function.

M F Lokhandwala.   

Abstract

Bromocriptine, a dopamine receptor agonist, lowered arterial blood pressure and caused significant impairment of the cardioacceleration observed during the stimulation of the right postganglionic cardiac sympathetic nerve fibers in pentobarbital-anethetized dogs. Prior administration of pimozide antagonized the hypotensive and the inhibitory action of bromocriptine on cardiac sympathetic function. These results suggest that while presynaptic dopamine receptors seem to be involved in mediating the inhibitory action of bromocriptine on cardiac sympathetic function, the role of presynaptic as well as dopamine receptors located at other sites in mediating the hypotensive action of bromocriptine needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477721     DOI: 10.1016/0014-2999(79)90178-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  In vivo and in vitro dopaminergic effects of three ergoline fragments.

Authors:  J C Koons; J P Long; J G Cannon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

2.  Involvement of the adrenal glands in the hypotensive response to bromocriptine in spontaneously hypertensive rats.

Authors:  T C Hamilton
Journal:  Br J Pharmacol       Date:  1981-03       Impact factor: 8.739

3.  Hypotensive and bradycardic effects of talipexole (B-HT 920) in anaesthetized rabbits are antagonized by metoclopramide but not by yohimbine.

Authors:  R Palluk; J C Schilling; K Stockhaus; H Peil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

4.  Involvement of central dopamine receptors in the hypotensive action of pergolide.

Authors:  A L Jadhav; R N Willett; H N Sapru; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

5.  Radioligand binding and autoradiographic analysis of dopamine receptors in the human heart.

Authors:  F Amenta; P Gallo; A Rossodivita; A Ricci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

6.  Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects.

Authors:  G Mercuro; Z L Rossetti; L Tocco; C A Rivano; A Cherchi; G L Gessa
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.